Lisa Gill
Stock Analyst at JP Morgan
(3.02)
# 2,523
Out of 5,182 analysts
141
Total ratings
45.19%
Success rate
0.36%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Neutral | $9 → $7 | $5.85 | +19.66% | 10 | Mar 13, 2026 | |
| MDLN Medline | Maintains: Overweight | $50 → $53 | $45.23 | +17.18% | 2 | Mar 10, 2026 | |
| GDRX GoodRx Holdings | Downgrades: Neutral | n/a | $2.28 | - | 3 | Feb 27, 2026 | |
| LH Labcorp Holdings | Maintains: Overweight | $319 → $330 | $263.43 | +25.27% | 4 | Feb 18, 2026 | |
| CAH Cardinal Health | Maintains: Neutral | $209 → $243 | $202.34 | +20.09% | 7 | Feb 10, 2026 | |
| COR Cencora | Maintains: Overweight | $417 → $419 | $310.16 | +35.09% | 4 | Feb 10, 2026 | |
| MCK McKesson | Maintains: Overweight | $983 → $1,107 | $828.32 | +33.64% | 15 | Feb 10, 2026 | |
| ELV Elevance Health | Maintains: Overweight | $394 → $397 | $356.13 | +11.48% | 7 | Feb 2, 2026 | |
| UNH UnitedHealth Group | Maintains: Overweight | $425 → $389 | $354.69 | +9.67% | 11 | Feb 2, 2026 | |
| CVS CVS Health | Maintains: Overweight | $93 → $101 | $78.36 | +28.89% | 6 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $23 | $20.95 | +9.79% | 6 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $32 → $33 | $24.41 | +35.19% | 6 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $25 → $26 | $18.41 | +41.23% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $428 → $375 | $282.58 | +32.71% | 14 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $6 → $10 | $6.75 | +48.15% | 3 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $190 | $196.63 | -3.37% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $29 → $30 | $22.67 | +32.33% | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $40 → $41 | $27.93 | +46.80% | 4 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $257 → $256 | $223.62 | +14.48% | 6 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $18 | $35.27 | -48.97% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 | $8.10 | -38.27% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $14.54 | +92.57% | 4 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $10.04 | +79.28% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $179.22 | +120.40% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $179.51 | +3.62% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $185.53 | -24.54% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $445.77 | -25.52% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $425 → $225 | $25.32 | +788.63% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $7.27 | +10.04% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $77.20 | +7.51% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $43.50 | +125.29% | 1 | Jan 6, 2023 |
Teladoc Health
Mar 13, 2026
Maintains: Neutral
Price Target: $9 → $7
Current: $5.85
Upside: +19.66%
Medline
Mar 10, 2026
Maintains: Overweight
Price Target: $50 → $53
Current: $45.23
Upside: +17.18%
GoodRx Holdings
Feb 27, 2026
Downgrades: Neutral
Price Target: n/a
Current: $2.28
Upside: -
Labcorp Holdings
Feb 18, 2026
Maintains: Overweight
Price Target: $319 → $330
Current: $263.43
Upside: +25.27%
Cardinal Health
Feb 10, 2026
Maintains: Neutral
Price Target: $209 → $243
Current: $202.34
Upside: +20.09%
Cencora
Feb 10, 2026
Maintains: Overweight
Price Target: $417 → $419
Current: $310.16
Upside: +35.09%
McKesson
Feb 10, 2026
Maintains: Overweight
Price Target: $983 → $1,107
Current: $828.32
Upside: +33.64%
Elevance Health
Feb 2, 2026
Maintains: Overweight
Price Target: $394 → $397
Current: $356.13
Upside: +11.48%
UnitedHealth Group
Feb 2, 2026
Maintains: Overweight
Price Target: $425 → $389
Current: $354.69
Upside: +9.67%
CVS Health
Dec 17, 2025
Maintains: Overweight
Price Target: $93 → $101
Current: $78.36
Upside: +28.89%
Dec 17, 2025
Maintains: Overweight
Price Target: $20 → $23
Current: $20.95
Upside: +9.79%
Nov 13, 2025
Maintains: Overweight
Price Target: $32 → $33
Current: $24.41
Upside: +35.19%
Nov 11, 2025
Maintains: Neutral
Price Target: $25 → $26
Current: $18.41
Upside: +41.23%
Nov 4, 2025
Maintains: Overweight
Price Target: $428 → $375
Current: $282.58
Upside: +32.71%
Sep 18, 2025
Upgrades: Neutral
Price Target: $6 → $10
Current: $6.75
Upside: +48.15%
May 6, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $196.63
Upside: -3.37%
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $22.67
Upside: +32.33%
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $27.93
Upside: +46.80%
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $223.62
Upside: +14.48%
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $35.27
Upside: -48.97%
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $8.10
Upside: -38.27%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $14.54
Upside: +92.57%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $10.04
Upside: +79.28%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $179.22
Upside: +120.40%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $179.51
Upside: +3.62%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $185.53
Upside: -24.54%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $445.77
Upside: -25.52%
Jan 5, 2024
Downgrades: Neutral
Price Target: $425 → $225
Current: $25.32
Upside: +788.63%
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $7.27
Upside: +10.04%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $77.20
Upside: +7.51%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $43.50
Upside: +125.29%